Jeroen van de Pol

153 5 Preferences of patients regarding community pharmacy services: A discrete choice experiment References [1] Mossialos E, Courtin E, Naci H et al. From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119:628-39. [2] Velzel E, Heida JP, Cozijnsen M. Versterking van de zorgfunctie van openbaar apothekers. 28 maart 2018. URL: https://www.knmp.nl/downloads/rapport-versterking-van-de-zorgfunctie- van-openbaar-apothekers.pdf/view [3] Bridges JF, Hauber AB, Marshall D et al. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403-13. [4] Gammie SM, Rodgers RM, Loo RL et al. Medicine-related services in community pharmacy: public preferences for pharmacy attributes and promotional methods and comparison with pharmacists' perceptions. Patient Prefer Adherence. 2016;10:2297-307. [5] Cipolle RJ, Strand LM, Morley PC (1998). Pharmaceutical Care Practice. New York: McGraw-Hill Health Professions Division. [6] Melton BL, Lai Z. Review of community pharmacy services: what is being performed, and where are the opportunities for improvement? Integr Pharm Res Pract. 2017;6:79–89. [7] Pharmaceutical Services Negotiating Committee (PSNC). NHS Community Pharmacy Contractual Framework Enhanced Service – Minor Ailment Service. Version 1, 6 September 2005. URL: https://psnc.org.uk/?our-services=minor-ailments-service [8] Australian Government Department of Health. Sixth Community Pharmacy Agreement. 24 may 2015. URL: https://www.pbs.gov.au/info/general/sixth-community-pharmacy-agreement [9] Canadian Pharmacists Association. Publicly Funded Pharmacy Services by Province. October 2015. URL: https://www.pharmacists.ca/cpha-ca/assets/File/pharmacy-in-canada/Publicly- Funded%20Pharmacy%20Services%20by%20Province(1).pdf [10] Van de Pol JM, van Dijk L, Koster ES et al. How does the general public balance convenience and cognitive pharmaceutical services in community pharmacy practice. Res Social Adm Pharm. 2020 May 28. Epub ahead of print. [11] Stichting Farmaceutische Kengetallen (SFK). Data en Feiten 2020; Het jaar 2019 in cijfers. ISBN/ EAN 978-90-830805-0-5. [12] Hiligsmann M, Dellaert BG, Dirksen CD et al. Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment. Rheumatology (Oxford). 2017;1;56(7):1167-76. [13] Lee HJ, Bae EY. Eliciting preferences for medical devices in South Korea: A discrete choice experiment. Health Policy. 2017;121(3):243-9. [14] FeehanM, WalshM, Godin J et al. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study. J Clin Pharm Ther. 2017;42(6):738-49. [15] Tinelli M, Ryan M, Bond C. Patients' preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract. 2009;17(5):275-82. [16] Whitty JA, Kendall E, Sav A et al. Preferences for the delivery of community pharmacy services to help manage chronic conditions. Res Social Adm Pharm. 2015;11(2):197-215.